Stock SLRX SALARIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Salarius Pharmaceuticals, Inc.

Equities

SLRX

US79400X4043

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-05 pm EDT 		5-day change 1st Jan Change
2.275 USD -5.99% Intraday chart for Salarius Pharmaceuticals, Inc. -4.41% -56.25%
Jun. 17 Clinical Data on Salarius Pharmaceuticals? Seclidemstat in Patients with Mds and Cmml Presented At the 2024 European Hematology Association Annual Meeting CI
May. 13 Salarius Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SALARIUS PHARMACEUTICALS, INC. Stock Salarius Pharmaceuticals, Inc.
 1.36M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 45.34B -
LONZA GROUP AG Stock Lonza Group AG
 40.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.92B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.75B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.71B
  1. Stock Market
  2. Equities
  3. SLRX Stock
  4. Charts Salarius Pharmaceuticals, Inc.
  5. Sector Chart